EUCTR2006-005862-38-BE进行中（未招募）不适用
Prevention of Postmenopausal Bone Loss in Osteopenic Women with Alendronate given on a 70 mg Once-every two week Regimen : a 2-year, Double-blind, Placebo-controlled Clinical Trial
CL Mont Godinne0 个研究点目标入组 150 人开始时间: 2007年3月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- female aged 45-60 years,
- •- post menopausal for at least 6 months,
- •- BMD between -1 and -2.5 T-scores,
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- former treatment susceptible of modifying the bone metabolism
研究者
相似试验
已完成
3 期
Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal WomenOsteopeniaOsteoporosisNCT00043719National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)200
进行中（未招募）
不适用
PREVENCIÓN DE LA PÉRDIDA DE MASA ÓSEA EN MUJERES POSTMENOPÁUSICAS CON OSTEOPENIA EN COLUMNA LUMBAR (PREPEMO)PREVENTION OF BONE DENSITY LOSS IN LUMBAR SPINE IN OSTEOPENIC POSTMENOPAUSAL WOMEN (PREPEMO) - PREPEMOOsteopeniaMedDRA version: 9.1Level: LLTClassification code 10049088Term: OsteopeniaEUCTR2007-001030-13-ESIMAS
已完成
3 期
Osteoporosis Prevention With Low Dose AlendronateOsteopeniaNCT00463268University Hospital of Mont-Godinne83
已完成
不适用
Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper LimbOsteoporosis With Current Fragility FractureNCT01780012Hospices Civils de Lyon436
进行中（未招募）
3 期
Bisphosphonate and Anastrozole trial - Bone Maintenance Algorithm AssessmentCancer - BreastBreast CancerACTRN12605000003673Barwon Health300